Peter Mullen
Impact in
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 6
- Cancer, Lipids, and Metabolism 6
- Oncology 16
- HER2/EGFR in Cancer Research 8
- Co-authors
- Simon P. Langdon (27 shared papers)Linda Z. Penn (6 shared papers)Rosemary Yu (5 shared papers)David James Harrison (36 shared papers)Joseph Longo (3 shared papers)Michael C. Archer (1 shared paper)Dana Faratian (14 shared papers)William R. Miller (7 shared papers)
- Journals
- British Journal of Cancer (8 papers)Cancer Research (6 papers)Oncotarget (5 papers)Clinical Cancer Research (3 papers)PLoS ONE (3 papers)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Peter Mullen
65 papers receiving 2.9k citations
Peter Mullen's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 883
- Oncology 447
- Reproductive Medicine 189
- Molecular Biology 834
- Pulmonary and Respiratory Medicine 217
Countries citing papers authored by Peter Mullen
This map shows the geographic impact of Peter Mullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mullen more than expected).
Fields of papers citing papers by Peter Mullen
This network shows the impact of papers produced by Peter Mullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mullen. The network helps show where Peter Mullen may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Mullen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The interplay between cell signalling and the mevalonate pathway in cancer Hit paper breakdown → | 2016 | 553 |
| 2 | 2012 | 167 | |
| 3 | 2010 | 153 | |
| 4 | 2009 | 137 | |
| 5 | 2005 | 132 | |
| 6 | 1997 | 89 | |
| 7 | 2015 | 77 | |
| 8 | 2014 | 75 | |
| 9 | 2014 | 72 | |
| 10 | 2019 | 69 | |
| 11 | 2001 | 63 | |
| 12 | 2012 | 60 | |
| 13 | 2017 | 59 | |
| 14 | 2013 | 58 | |
| 15 | 1996 | 57 | |
| 16 | 2015 | 57 | |
| 17 | 2007 | 53 | |
| 18 | 2011 | 52 | |
| 19 | 2017 | 52 | |
| 20 | 2003 | 49 |
About Peter Mullen
Peter Mullen is a scholar working on Cancer Research, Oncology, Reproductive Medicine, Molecular Biology and Genetics, having authored 67 papers that have together received 2.9k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (9 papers), HER2/EGFR in Cancer Research (8 papers), Renal cell carcinoma treatment (6 papers), Ovarian cancer diagnosis and treatment (6 papers), Breast Cancer Treatment Studies (6 papers), Cancer, Lipids, and Metabolism (6 papers), Enzyme function and inhibition (3 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Cancer Research (883 citations), Oncology (447 citations), Reproductive Medicine (189 citations), Molecular Biology (834 citations) and Pulmonary and Respiratory Medicine (217 citations). Peter Mullen has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Simon P. Langdon, Linda Z. Penn, Rosemary Yu, David James Harrison, Joseph Longo, Michael C. Archer, Dana Faratian, William R. Miller, Carol Ward and John F. Smyth. Their work appears in journals such as British Journal of Cancer, Cancer Research, Oncotarget, Clinical Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.